OR WAIT null SECS
May 25, 2023
Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.
May 23, 2023
uBriGene Biosciences will acquire Mustang Bio’s Worcester, Mass., CGT manufacturing facility in a deal worth up to $11 million, expanding its operations into the US market.
May 16, 2023
Synthego has opened its new GMP-compliant RNA manufacturing facility in Redwood City, Calif., for CRISPR-enabled genomics therapeutics.
May 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.
May 01, 2023
Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.
April 14, 2023
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
March 01, 2023
The trends shaping the growth of the biologics outsourcing industry demand attention.
February 13, 2023
The technology is designed to enable patients to self-inject biologic-based therapies at home instead of a hospital setting.